Genetically engineered polymers: status and prospects for controlled release

J Control Release. 2004 Feb 20;95(1):1-26. doi: 10.1016/j.jconrel.2003.11.011.

Abstract

Genetic engineering methodology has enabled the synthesis of protein-based polymers with precisely controlled structures. Protein-based polymers have well-defined molecular weights, monomer compositions, sequences and stereochemistries. The incorporation of tailor-made motifs at specified locations by recombinant techniques allows the formation of hydrogels, sensitivity to environmental stimuli, complexation with drugs and nucleic acids, biorecognition and biodegradation. Accordingly, a special interest has emerged for the use of protein-based polymers for controlled drug and gene delivery, tissue engineering and other biomedical applications. This article is a review of genetically engineered polymers, their physicochemical characteristics, synthetic strategies used to produce them and their biomedical applications with emphasis on controlled release.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Delayed-Action Preparations*
  • Drug Delivery Systems
  • Elastin
  • Gene Transfer Techniques
  • Genetic Engineering*
  • Humans
  • Insect Proteins
  • Microspheres
  • Polyglutamic Acid / chemistry
  • Polymers / chemistry*
  • Protein Structure, Secondary
  • Proteins / chemistry
  • Silk

Substances

  • Delayed-Action Preparations
  • Insect Proteins
  • Polymers
  • Proteins
  • Silk
  • Polyglutamic Acid
  • Elastin